Is there a Possible Association between Multiple Myeloma Relapse and Coronavirus Disease 2019 Vaccination? A Case Report
View abstract on PubMed
Summary
This summary is machine-generated.This case study explores a potential link between COVID-19 vaccination and multiple myeloma (MM) relapse. While MM patients should receive the vaccine, careful monitoring post-vaccination is advised.
Area Of Science
- Oncology
- Immunology
- Vaccinology
Background
- Coronavirus disease 2019 (COVID-19) poses significant risks to cancer patients, highlighting the need for vaccination.
- Multiple myeloma (MM) patients are a vulnerable group requiring specific consideration for COVID-19 vaccination.
- Existing research confirms the safety of COVID-19 vaccines in MM patients, but the impact on disease relapse remains under-investigated.
Related Concept Videos
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

